🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with glp-1 hepatoprotection? Page 4

Has anyone dealt with glp-1 hepatoprotection?

GenomicsKate Fri, Jul 11, 2025 at 12:32 PM 33 replies 1,678 viewsPage 4 of 7
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
Jul 15, 2025 at 6:45 AM#16

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Last edited: Jul 15, 2025 at 10:45 AM
8 6DerekSJ_a1c, paige_pharma, emma_london and 5 others
Reply Quote Save Share Report
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Jul 15, 2025 at 5:57 PM#17

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

9 7Dr.DermMIA, fiona_VT, denise_HTX and 6 others
Reply Quote Save Share Report
tom_AK
New Member
28
112
Jan 2026
Anchorage, AK
Jul 16, 2025 at 5:09 AM#18

Following on from HPLC_Greg — and this may be the naive question:

What would you measure differently if you were starting again?

10 8tyler_CSCS, VanRx_Mike, steve_okc and 7 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Jul 16, 2025 at 4:21 PM#19
DanielChem_CHI said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

This is where I part company with the consensus forming above. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

11 9DoseLogDan, SleepFixSam, PurityPaulOR and 8 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jul 17, 2025 at 3:32 AM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.

33 6PurityPaulOR, MaxMetOK, MounjBrad and 30 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register